Emerald Acquisition’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$77.5M Sell
965,149
-85,752
-8% -$6.86M 0.15% 152
2016
Q2
$82.7M Buy
+1,050,901
New +$79.1M 0.14% 165

Other funds holding LLY

Emerald Acquisition's LLY Position: Q3 2016 in Review

Emerald Acquisition reduced its Eli Lilly (LLY) stake by 8.2% in Q3 2016, selling an estimated $6.86M and leaving 965,149 shares worth $77.5M. The position accounts for 0.15% of the portfolio, ranked #152.

Emerald Acquisition first reported a position in LLY in Q2 2016 and has held it in 2 quarters since. The position peaked at $82.7M in Q2 2016. 1,176 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Emerald Acquisition held 965,149 shares of Eli Lilly worth $77.5M as of Q3 2016.
  • Emerald Acquisition sold 85,752 Eli Lilly shares in Q3 2016, an estimated $6.86M.
  • Eli Lilly made up 0.15% of Emerald Acquisition's portfolio in Q3 2016, its #152 holding.
  • Emerald Acquisition first reported a position in Eli Lilly in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Eli Lilly position peaked at $82.7M in Q2 2016.
  • 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.